Información del artículo
El Texto completo está disponible en PDF
Referencias bibliográficas
[1.]
Casazza A.R., Duvall C.P., Carbone P.P..
Infection in lymphoma. Histology, treatment, and duration in relation to incidence and survival.
JAMA, 197 (1966), pp. 710-716
[2.]
Hersch E.M., Bodey G.P., Nies B.A., Freireich E.J..
Causes of death in acute leukemia A ten-year study of 414 patients from 1954-1963.
JAMA, (1965), pp. 105
[3.]
Santos J.L..
Nutrition, infection and inmunocompetence.
Infect Dis Clin North Am, 8 (1994), pp. 243-267
[4.]
Styrt B..
Infection associated with asplenia: risks, mechanisms, and prevention.
Am J Med, 88 (1990), pp. 33N-42N
[5.]
Schimpff S.C., Young V., Greene W., Vermeulen G.D., Moody M.R., Wiernik P.H..
Origin of infection in acute nonlymphocytic leukemia: significance of hospital acquisition of potencial pathogens.
Ann Intern Med, 77 (1972), pp. 707-714
[6.]
Mackowiak P.A., Wasserman S.S., Levine M.M..
A critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich.
JAMA, 268 (1992), pp. 1578-1580
[7.]
Feld R., Bodey G.P., Groschel D..
Mycobacteriosis en patients with malignant disease.
Arch Intern Med, 136 (1976), pp. 67-70
[8.]
Skogberg, Ruutu P., Tukianien P., Valtonen V..
Effect of inmunosuppresive therapy on the clinical presentation and outcome of tuberculosis.
Clin Infect Dis, 117 (1993), pp. 1012-1017
[9.]
Freifeld A.G., Walsh T.J., Pizzo P.A..
Infections in the cancer patient.
Cancer. Principles and practice of Oncology, 5ª, pp. 2659-2704
[10.]
Sepkowitz K.A., Brown A.E., Telzak E.E., Gotlieb S., Armstrong D..
Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital.
JAMA, 267 (1992), pp. 832-837
[11.]
Jones J.M..
Pneumonia due to Candida, Aspergillus and Mucaroles species.
Respiratory disease in the inmunosuppresed host, pp. 338
[12.]
Hughes W.T., Armstrong D., Bodey G.P., Feld R., Mandell G.L., Meyers J.D., et al.
From the Infectius Diseases Society of America, Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever: statement by the Infectious Disease Society of America.
J Infects Dis, 161 (1990), pp. 381-396
[13.]
Hughes W.T., Armstrong D., Bodey G.P., Brown A.E., Edwards J.E., Feld R., et al.
Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.
Clin Infect Dis, 25 (1997), pp. 551-573
[14.]
Pizzo P.A..
Management of fever in patients with cancer and treatment-induced neutropenia.
N Eng J Med, 328 (1993), pp. 1323-1332
[15.]
Pizzo P.A..
Evaluation of fever in the patient with cancer.
Eur J Cancer Clin Oncol, 25 (1989), pp. 9-16
[16.]
Klastersky J., Paesmans M., Rubenstein E.B., Bayer M., Elting L., Feld R., et al.
The Multinational Association for Supportive Care in Cancer: A multinational scoring system for identifiyng lowrisk febrile neutropenic cancer patients.
J Clin Oncol, 18 (2000), pp. 3038-3051
Copyright © 2004. Academia de Ciencias Médicas de Bilbao